Skip to content
Screener

Total Liabilities at other companies

ResMed logo
ResMedRMD
$2.38B+7.9%
LivaNova logo
LivaNovaLIVN
$195.09M-85.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$443.84M+17.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$0
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$74.58M+640%
Globus Medical logo
Globus MedicalGMED
$719.66M+8.2%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemMarch 31, 2026December 31, 2025
Total current liabilities89,41896,055
Operating lease liabilities, non-current portion29,55229,998
Other non-current liabilities66104
Total liabilities119,036126,157
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common Stock, $0.001 par value; 200,000,000 shares authorized; 28,802,039 and 28,579,015 issued and outstanding at March 31, 2026 and December 31, 2025, respectively2929

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's total liabilities?
Inspire Medical Systems (INSP) reported total liabilities of $119.04M in Q1 2026.
How has Inspire Medical Systems's total liabilities changed year-over-year?
Inspire Medical Systems's total liabilities increased by 25.2% year-over-year, from $95.07M to $119.04M.
What is the long-term trend for Inspire Medical Systems's total liabilities?
Over 5 years (2020 to 2025), Inspire Medical Systems's total liabilities has grown at a 19.7% compound annual growth rate (CAGR), from $51.44M to $126.16M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Inspire Medical Systems's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude